Dublin, April 30, 2019 (GLOBE NEWSWIRE) -- The "Cell Expansion Market by Product, Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The cell expansion market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period.

Cell expansion deals with the mass production of cells from a given sample or tissue. The process includes scaling up of cells for the manufacturing of biological products such as vaccines, blood components, antibodies, somatic cells, and others. Products manufactured from the cell expansion process are utilized for treating diseases such as diabetes and cancer.

Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. The emerging markets and the 3D cell expansion technology are both expected to provide a wide range of growth opportunities for players in the market. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

Some of the leading players in the cell expansion market include Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Cell Expansion Market: Market Overview
4.2 North America: Cell Expansion Market, By Product (20
4.3 Geographical Snapshot of the Cell Expansion Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Chronic Diseases
5.2.1.2 Government Investments for Cell-Based Research
5.2.1.3 Growing Focus on Personalized Medicine
5.2.1.4 Increasing Focus on R&D for Cell-Based Therapies
5.2.1.5 Increasing GMP Certifications for Cell Therapy Production Facilities
5.2.2 Restraints
5.2.2.1 Ethical Concerns Regarding Research in Cell Biology
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 3D Cell Expansion Technology

6 Cell Expansion Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Media
6.2.1.1 Media Segment to Dominate the Cell Expansion Consumables Market
6.2.2 Reagents
6.2.2.1 Reagents Segment to Account for the Second-Largest Share of the Cell Expansion Consumables Market
6.2.3 Sera
6.2.3.1 North America to Dominate the Cell Expansion Sera Market
6.2.4 Disposables
6.2.4.1 Tissue Culture Flasks
6.2.4.1.1 Tissue Culture Flasks Segment Accounted for the Largest Share of the Disposables Market
6.2.4.2 Bioreactor Accessories
6.2.4.2.1 Bioreactor Accessories Segment Accounted for the Second-Largest Share of the Disposables Market
6.2.4.3 Other Disposables
6.3 Instruments
6.3.1 Cell Expansion Supporting Equipment
6.3.1.1 Flow Cytometers
6.3.1.1.1 Product Launches to Drive the Growth of This Market Segment
6.3.1.2 Centrifuges
6.3.1.2.1 Major Players are Focusing on Launching New and Advanced Centrifuges in the Market
6.3.1.3 Cell Counters & Hemocytometers
6.3.1.3.1 Technological Advancements Supporting the Growth of the Cell Counters & Hemocytometers Market
6.3.1.4 Other Supporting Equipment
6.3.2 Bioreactors
6.3.2.1 Microcarrier Bioreactors
6.3.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors
6.3.2.1.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors Offer Large-Scale Production
6.3.2.1.2 Suspension-Based Anchorage-Independent Bioreactors
6.3.2.1.2.1 North America is the Largest Market for Suspension-Based Anchorage-Independent Bioreactors
6.3.2.2 Perfusion/Hollow Fiber Bioreactors
6.3.2.2.1 Collaborations and Product Launches Supporting the Growth of This Market Segment
6.3.3 Automated Cell Expansion Systems
6.3.3.1 Technological Advancements to Drive the Growth of This Market Segment

7 Cell Expansion Market, By Cell Type
7.1 Introduction
7.2 Human Cells
7.2.1 Stem Cells
7.2.1.1 Adult Stem Cells
7.2.1.1.1 Adult Stem Cells Segment Accounts for the Largest Share of the Human Stem Cells Market, Primarily Due to Increased Government Initiatives in Cell-Based Research
7.2.1.2 Induced Pluripotent Stem Cells (IPSCS
7.2.1.2.1 IPSCS are Sued in Cell Replacement Therapies, Drug Screening, and Tissue Regeneration
7.2.1.3 Embryonic Stem Cells (ESCS
7.2.1.3.1 Increasing Private and Public Investments for Stem Cell Research - Major Factor Driving Market Growth
7.2.2 Differentiated Cells
7.2.2.1 Increasing Prevalence of Cancer is the Major Factor Driving the Growth of This Market
7.3 Animal Cells
7.3.1 Biopharmaceutical Companies are the Major End Users of Animal Cells

8 Cell Expansion Market, By Application
8.1 Introduction
8.2 Regenerative Medicine and Stem Cell Research
8.2.1 Increasing Government Funding on Regenerative Medicine and Stem Cell Research to Drive Market Growth
8.3 Cancer and Cell-Based Research
8.3.1 Increasing Prevalence of Cancer to Support Market Growth
8.4 Other Applications

9 Cell Expansion Market, By End User
9.1 Introduction
9.2 Biotechnology & Biopharmaceutical Companies
9.2.1 Increasing Investments in Cell-Based Research to Drive Market Growth
9.3 Research Institutes
9.3.1 Growth in Funding for Life Science Research to Drive the Market for Research Institutes
9.4 Cell Banks
9.4.1 Increasing Awareness Among People About the Benefits of Preserving Stem Cells to Drive Market Growth
9.5 Other End Users

10 Cell Expansion Market, By Region

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals, 2016-2019
11.3.2 Acquisitions, 2016-2019
11.3.3 Agreements, 2016-2019
11.3.4 Expansions, 2016-2019
11.4 Competitive Leadership Mapping (2018)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Differentiators
11.4.5 Emerging Companies

12 Company Profiles
12.1 Thermo Fisher Scientific, Inc.
12.2 Becton, Dickinson and Company
12.3 Terumo BCT
12.4 Merck KGaA
12.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation
12.6 Miltenyi Biotec
12.7 Lonza Group Ltd.
12.8 Stemcell Technologies, Inc.
12.9 GE Healthcare
12.10 Corning Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/cbxh8o

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.